As of September 1, 2026, Cytokinetics Inc (CYTK) is trading at $70.91. BlackOwl's AI analysis indicates a bullish outlook with 70% confidence and a price target of $82.50 (16.3% above the current price).

C

CYTK

$70.91 bullish

Cytokinetics Inc

Trade
No chart data available for this period

Over a 2-week timeframe, CYTK displays a constructive recovery pattern supported by fundamental catalysts and clinical validation. A target of $82.50 reflects successful retest and breakout past immediate overhead resistance.

Trend

bullish

Confidence

70%

Price Target

$82.50

+16.3% from current

Timeframe

2 Weeks

Until 9/12/2026

Key Insights

  • Medium-term trend stabilization as market digests robust clinical trial updates
  • Price action poised to challenge the 2-week resistance near $81.80

Risk Factors

  • Broader healthcare sector rotation could impede momentum
  • MACD remains slightly negative, requiring confirmation via volume breakout

Actionable Items

  • Monitor volume expansion on tests of the $81.80 resistance zone
  • Maintain core long positions while price holds above the 50-day SMA

News Sentiment

News Count

8

Impact Level

medium

Sentiment

Positive

Key Topics

ACACIA-HCMMAPLE-HCMmarket expansion

Key Statistics

P/E Ratio —
Forward P/E —
EPS (TTM) —
Beta —
Div. Yield —
ROE —
ROA -56.76%
ROI -85.25%
52W High —
52W Low —
Dividend —
Market Cap —

New to reading these? Start with how to research stocks.

Related Tickers

L
LLY

Lilly(Eli) & Co

$1,156.73
-1.5%
J
JNJ

Johnson & Johnson

$265.85
-0.8%
A
ABBV

Abbvie Inc

$256.42
+0.4%
M
MRK

Merck & Co Inc

$147.76
-0.4%
U
UNH

Unitedhealth Group Inc

$389.41
-0.9%

Frequently Asked Questions

What is Cytokinetics Inc's current stock price?
As of September 1, 2026, Cytokinetics Inc (CYTK) is trading at $70.91 per share. This is AI-generated analysis for informational purposes only, not financial advice.
What does BlackOwl's AI model project for CYTK?
BlackOwl's model reads CYTK as bullish in the medium term with 70% confidence, with a price target of $82.50 — 16.3% above the current price of $70.91. This is AI-generated analysis for informational purposes only, not financial advice.
What is CYTK's P/E ratio?
P/E ratio data is not currently available for CYTK. This is AI-generated analysis for informational purposes only, not financial advice.
How do I buy CYTK stock?
You can buy Cytokinetics Inc (CYTK) directly through BlackOwl with one click. Sign up for a free account, connect your brokerage, and trade instantly. This is AI-generated analysis for informational purposes only, not financial advice.

Get AI-powered insights for CYTK

Unlock real-time signals, personalized risk analysis, and trade recommendations.

Try BlackOwl Free